MIMETAS
PrivateLast Round
Grant
Jul 7, 2024
Total Funding Raised
$32.96M
Company Overview
MIMETAS is a biotechnology company that develops and markets organ-on-a-chip products and 3D tissue models for drug development, compound testing, and research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MIMETAS Comparables
Compare MIMETAS with similar companies based on industry and business-model similarity.
MIMETAS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 7, 2024 | ||||
| Grant | Feb 22, 2022 | ||||
| Series B | Apr 11, 2018 | ||||
| Grant | Dec 22, 2015 | ||||
| Series A | Oct 8, 2014 | ||||
Grant | Sep 11, 2014 |
Key People
Founding team and executive leadership
MIMETAS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission (Horizon Europe) | Grant |
| Zeeuws InvesteringsFonds | Series A |
| NC3Rs | Grant |
| Korys | Series B |
| European Life Sciences Growth Fund | Series B |
| Institute for Risk Assessment Sciences | Grant |
| Cathay Venture | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2025
Attended SLAS 2025 and launched new OrganoPlate UniFlow technology.
- Jan 27, 2025
OrganoPlate UniFlow technology unveiled at SLAS 2025.
MIMETAS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MIMETAS's valuation, stock price, and market status.